Site Temporarily Unavailable The Business Wire site is currently unavailable, but will be back shortly. To Access Business Wire News In the interim, to access news releases from members, visit Yahoo Finance or any other web portal. Die von Ihnen aufgerufene Internetseite steht aufgrund planmäßiger Wartungsarbeiten derzeit nicht zur Verfügung.Das System steht in Kürze wieder zur Verfügung. Wenn Sie Kunde sind und versucht haben, eine Pressemitteilung zu senden, wenden Sie sich bitte an die für Siezuständige ...

Core Insights - Acadia Healthcare has appointed Todd Young as the new chief financial officer in response to increasing pressure from activist investors to enhance performance and governance [1] Company Developments - The appointment of Todd Young is a strategic move by Acadia Healthcare to address the demands of activist investors [1] - The company is facing scrutiny regarding its performance and governance practices, indicating a need for improvement [1]

Core Insights - Activist investors are focusing on Acadia Healthcare (ACHC), which has faced challenges such as federal investigations and operational issues, leading to a decline in stock performance [1][6] - Engine Capital acquired approximately 3% of Acadia, resulting in a nearly 12% increase in stock price on the same day, and has called for significant changes in the company's strategy and board composition [2][3] - Acadia Healthcare is one of the largest behavioral healthcare providers in the U.S., operating over 260 facilities and employing around 25,000 staff [4][5] Company Overview - Acadia Healthcare is valued at approximately $2.5 billion, but its stock has decreased nearly 52% over the past year, contrasting with a 17% gain in the S&P 500 Index [6] - The company operates a diverse range of behavioral healthcare facilities, including inpatient psychiatric hospitals and outpatient clinics, with around 11,800 beds available [4][5] - Recent activist involvement has led to a 10% rebound in stock price over five trading days, indicating a potential shift in market sentiment [6]

Group 1 - Acadia Healthcare Company, Inc. (ACHC) has been added to the Zacks Rank 5 (Strong Sell) List due to a 4.9% downward revision in the consensus estimate for its current year earnings over the last 60 days [1] - Allison Transmission Holdings, Inc. (ALSN) is also on the Zacks Rank 5 (Strong Sell) List, with a 5.5% downward revision in the consensus estimate for its current year earnings over the last 60 days [2] - Black Stone Minerals, L.P. (BSM) has seen a 10.5% downward revision in the consensus estimate for its current year earnings over the last 60 days, leading to its inclusion in the Zacks Rank 5 (Strong Sell) List [2]

Core Insights - Acadia Healthcare is a leading provider in the behavioral healthcare sector, offering a range of services including psychiatric and addiction treatment [1] - The company is facing challenges related to governance and performance, as highlighted by a major shareholder's call for a strategic review [3] Stock Performance - On October 3, 2025, Raymond James upgraded Acadia Healthcare to "Outperform" with a new price target of $30, up from $26, indicating a positive outlook for the stock [2][5] - ACHC's stock price increased by 8.43%, or $2.07, reflecting strong investor interest, with a trading range of $24.57 to $26.72 for the day [4][5] - Over the past year, ACHC has experienced significant volatility, with a high of $60.52 and a low of $17.13 [4] Market Position - Acadia Healthcare's market capitalization is approximately $2.46 billion, indicating its substantial presence in the market [4] - The trading volume for ACHC today was 3,511,931 shares on the NASDAQ exchange, demonstrating active investor engagement [4]

Core Viewpoint - Khrom Capital Management, a major shareholder of Acadia Healthcare, is urging the company's board to initiate a formal strategic review, which may include a potential sale, due to years of underperformance [1] Group 1 - Khrom Capital Management is one of the largest shareholders of Acadia Healthcare [1] - The call for a strategic review is based on the company's prolonged poor performance [1] - The potential sale is part of the strategic options being considered [1]

Core Insights - Acadia Healthcare is one of the largest operators of behavioral health facilities in the U.S. [1] - The company is participating in the 2025 Jefferies Healthcare Services Conference, indicating its active engagement with investors and stakeholders [1] Company Announcements - Acadia Healthcare issued an 8-K filing, which includes important announcements regarding recent activism directed at the company [2] - The CEO of Acadia Healthcare, Hunter, is addressing the activism and related announcements during the conference [2]

Acadia Healthcare Company Conference Call Summary Company Overview - Acadia Healthcare Company is one of the largest operators of behavioral health facilities in the U.S. [1] Core Industry Insights - The demand for behavioral health services remains structurally strong, particularly for patients with rising acuity and comorbidities [17] - There is a supply-demand imbalance in behavioral health, especially in underserved areas [17] - The company is focused on delivering high-quality, evidence-based behavioral health services [2] Financial Performance and Guidance - 2025 has been a challenging year for Acadia, with volumes coming in below expectations due to weaker Medicaid volumes [2][3] - The company has paused several projects, reducing 2026 CapEx by at least $300 million compared to 2025 levels [4][12] - Acadia added nearly 1,800 beds between 2024 and 2025 and expects to add an additional 500 to 700 beds in 2026 [4][7] - The company anticipates significant improvement in EBITDA growth and free cash flow generation in 2026 and 2027 [7][8] Operational Strategy - Acadia is taking a more measured approach to capital deployment, focusing on markets with favorable reimbursement environments [13][18] - The company has closed five underperforming facilities to concentrate resources on core business areas [23] - A comprehensive review of facilities is ongoing, with five additional facilities being monitored for potential closure [26] Medicaid Dynamics - Challenges in the acute line of business include payer behavior, leading to denials and reduced lengths of stay for patients [9][10] - The company is experiencing tighter scrutiny from managed Medicaid plans [10] Capital Expenditure and Investment - The decision to cut CapEx was driven by a thorough review of growth opportunities and market demand [11][12] - Acadia is focusing on optimizing capital deployment and enhancing shareholder value through strategic facility closures [22][28] Quality and Technology Investments - Acadia has made significant investments in technology and quality infrastructure, which are expected to improve clinical outcomes and operational consistency [20][47] - The company tracks over 50 key performance indicators (KPIs) to ensure quality and operational efficiency [47] Market Position and Competitive Landscape - Acadia differentiates itself through technology and quality, addressing the historical underinvestment in behavioral health [20] - The company is well-positioned to leverage its joint venture partnerships for reimbursement advantages [41] Future Outlook - Acadia expects to unlock free cash flow potential and achieve strong top and bottom line growth in the coming years [48] - The company is closely monitoring the evolving reimbursement environment, particularly with upcoming changes in state-directed payments [44][46] Key Takeaways - The depth of Acadia's quality infrastructure and operational discipline is often underappreciated by investors [47] - The company is committed to sustainable growth and long-term expansion despite current challenges [48]

Core Insights - Acadia Healthcare Company, Inc. (ACHC) shares increased by 11.7% following Engine Capital's announcement of a 3% stake and a call for significant changes within the company [1][6] - Engine Capital believes Acadia is undervalued due to strong cash generation and real estate, which have been overshadowed by poor execution and management issues [2][3] - ACHC's current forward P/E ratio is 8.87X, significantly lower than its five-year median of 20.55X and the industry average of 13.55X, indicating potential for operational improvements to unlock value [3][4] Company Performance - ACHC's stock has declined by 67.5% over the past year, compared to a 5.8% decline in the industry, exacerbated by a Department of Justice investigation into alleged misconduct [4][6] - The Zacks Consensus Estimate for ACHC's 2025 earnings is $2.54 per share, reflecting a 23% decrease year-over-year [11] Proposed Changes by Engine Capital - Engine Capital is advocating for a board refresh with directors experienced in behavioral health and capital allocation, realigning executive compensation, and pausing aggressive expansion [7] - The proposal includes streamlining operations, reinstating a regional leadership model, and monetizing select assets to fund buybacks, aimed at restoring investor trust and closing the valuation gap [7] Industry Context - Competitors like Tenet Healthcare Corporation (THC) and HCA Healthcare, Inc. (HCA) are experiencing growth due to rising demand from an aging population and increased disease cases [9][10] - THC is benefiting from higher patient revenue and strategic divestitures, while HCA is leveraging increased admissions and a broad healthcare services network [10]

Core Viewpoint - Activist investor Engine Capital is urging Acadia Healthcare to restructure its board and reassess its growth strategy due to ongoing federal investigations and significant share price declines [1][2]. Group 1: Investor Pressure - Engine Capital holds approximately a 3% stake in Acadia, making it one of the company's ten largest shareholders [1]. - The hedge fund has called for a halt to costly new projects and a review of the asset portfolio [2][3]. - The letter highlights Acadia's consistent negative returns and underperformance compared to healthcare peers, resulting in shares being undervalued [2][5]. Group 2: Operational Concerns - Underperformance is attributed to poor execution, missteps in reorganization under CEO Christopher Hunter, rising costs, and inadequate board oversight [3][4]. - Engine Capital criticizes Acadia's "growth at any cost" strategy, which has led to an oversized corporate structure and limited operational improvements [4]. - The hedge fund emphasizes the need for a board refresh with directors who have experience in behavioral health and capital allocation [4][5]. Group 3: Financial Performance - Acadia's market value has significantly decreased, with shares down 71% over the past year, placing its equity valuation just above $2 billion [5]. - The stock price has recently seen a slight increase of 9.87%, reaching $24.19 [5].